Omnicell Reports Results for First Quarter 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Omnicell (OMCL) Tops Q1 EPS by 20c, Revenues Beat; Offers 2Q & FY19 EPS Guidance Above Consensus, Affirms 2Q & FY19 Revenue Outlooks
April 25, 2019 4:38 PM EDTOmnicell (NASDAQ: OMCL) reported Q1 EPS of $0.61, $0.20 better than the analyst estimate of $0.41. Revenue for the quarter came in at $202.5 million versus the consensus estimate of $199.72 million.
"We believe that customers and the market are embracing our Autonomous Pharmacy vision and the impact that... More
